Form 4: CFO Malatesta Sells SEM Shares for Tax Obligations

Select Medical Holdings CFO Michael F. Malatesta disposed of 7,357 shares of common stock to cover tax withholding obligations related to restricted stock vesting.

Summary

• Michael F. Malatesta, Chief Financial Officer of Select Medical Holdings Corp (SEM), disposed of 7,357 shares of common stock.
• The transaction occurred on November 1, 2025, at a price of $13.83 per share.
• The disposition was a surrender of shares to satisfy tax withholding obligations incident to the vesting of restricted stock.
• Following this transaction, Mr. Malatesta beneficially owns 238,057 shares of common stock directly.
• The filing also includes a Limited Power of Attorney, dated July 17, 2025, appointing John F. Duggan as attorney-in-fact for Section 16 reporting obligations.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax purposes related to executive compensation. It is neutral in terms of company performance or strategic direction, reflecting an expected event.

Positives

• The transaction indicates the vesting of restricted stock, which is a form of executive compensation and suggests continued alignment of management interests with shareholders.

Negatives

• The disposition of shares, while for tax purposes, reduces the direct ownership stake of the CFO, albeit by a small percentage relative to his total holdings.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4.

Industry Context

This filing is a routine insider transaction for tax purposes and does not provide specific insights into broader industry trends or competitive landscape. It reflects standard executive compensation practices within publicly traded companies.

Comparison to Industry Standards

• This is a standard tax-related disposition of shares upon vesting of restricted stock, a common practice for executives across various industries. No specific comparable companies or projects are mentioned or relevant for this type of filing.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal direct impact. The sale is for tax purposes and represents a small fraction of the CFO's total holdings, indicating no change in confidence.
• Management: The vesting of restricted stock is a positive for the CFO as part of his compensation package.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where the CFO sold shares to cover tax obligations upon the vesting of restricted stock. Such transactions are common and do not typically signal a change in management's outlook or the company's fundamentals. Therefore, it provides no new information to warrant a change in investment recommendation, suggesting a 'hold' position is appropriate based solely on this filing.

Keywords

Select Medical Holdings Corp, SEM, Form 4, Insider Transaction, Michael F. Malatesta, Chief Financial Officer, Stock Sale, Tax Withholding, Restricted Stock Vesting, Executive Compensation